TRAW
Price
$2.04
Change
-$1.09 (-34.82%)
Updated
Feb 3 closing price
Capitalization
16.46M
Intraday BUY SELL Signals
VTGN
Price
$0.54
Change
-$3.67 (-87.17%)
Updated
Feb 3 closing price
Capitalization
21.69M
Intraday BUY SELL Signals
Interact to see
Advertisement

TRAW vs VTGN

Header iconTRAW vs VTGN Comparison
Open Charts TRAW vs VTGNBanner chart's image
Traws Pharma
Price$2.04
Change-$1.09 (-34.82%)
Volume$22.94K
Capitalization16.46M
VistaGen Therapeutics
Price$0.54
Change-$3.67 (-87.17%)
Volume$1.1M
Capitalization21.69M
TRAW vs VTGN Comparison Chart in %
TRAW
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
TRAW vs. VTGN commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRAW is a Hold and VTGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (TRAW: $2.04 vs. VTGN: $0.54)
Brand notoriety: TRAW and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRAW: 6% vs. VTGN: 31%
Market capitalization -- TRAW: $16.46M vs. VTGN: $21.69M
TRAW [@Biotechnology] is valued at $16.46M. VTGN’s [@Biotechnology] market capitalization is $21.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRAW’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 1 green FA rating(s).

  • TRAW’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 1 green, 4 red.
According to our system of comparison, TRAW is a better buy in the long-term than VTGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRAW’s TA Score shows that 5 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • TRAW’s TA Score: 5 bullish, 5 bearish.
  • VTGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than TRAW.

Price Growth

TRAW (@Biotechnology) experienced а -27.66% price change this week, while VTGN (@Biotechnology) price change was -10.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($21.7M) has a higher market cap than TRAW($16.5M). TRAW YTD gains are higher at: 80.531 vs. VTGN (-17.873). TRAW has higher annual earnings (EBITDA): -15.77M vs. VTGN (-64.79M). VTGN has more cash in the bank: 77.2M vs. TRAW (6.42M). TRAW has higher revenues than VTGN: TRAW (2.85M) vs VTGN (721K).
TRAWVTGNTRAW / VTGN
Capitalization16.5M21.7M76%
EBITDA-15.77M-64.79M24%
Gain YTD80.531-17.873-451%
P/E Ratio0.50N/A-
Revenue2.85M721K395%
Total Cash6.42M77.2M8%
Total DebtN/A1.87M-
FUNDAMENTALS RATINGS
TRAW vs VTGN: Fundamental Ratings
TRAW
VTGN
OUTLOOK RATING
1..100
2483
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4396
P/E GROWTH RATING
1..100
21100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (15) in the Biotechnology industry is in the same range as TRAW (34). This means that VTGN’s stock grew similarly to TRAW’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TRAW (100). This means that VTGN’s stock grew similarly to TRAW’s over the last 12 months.

VTGN's SMR Rating (98) in the Biotechnology industry is in the same range as TRAW (100). This means that VTGN’s stock grew similarly to TRAW’s over the last 12 months.

TRAW's Price Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for VTGN (96). This means that TRAW’s stock grew somewhat faster than VTGN’s over the last 12 months.

TRAW's P/E Growth Rating (21) in the Biotechnology industry is significantly better than the same rating for VTGN (100). This means that TRAW’s stock grew significantly faster than VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TRAWVTGN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
TRAW
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEN64.050.05
+0.08%
New England Realty Associates Limited
IOBT0.28N/A
-0.58%
IO Biotech
OCSL12.14-0.10
-0.82%
Oaktree Specialty Lending Corp
MRVL75.54-3.12
-3.97%
Marvell Technology
KD22.21-1.10
-4.72%
Kyndryl Holdings

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with RAPT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then RAPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
N/A
RAPT - TRAW
45%
Loosely correlated
+0.12%
VTGN - TRAW
42%
Loosely correlated
-6.19%
SLGL - TRAW
42%
Loosely correlated
+2.47%
ORMP - TRAW
34%
Loosely correlated
+0.29%
TARA - TRAW
33%
Poorly correlated
-4.12%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with TRAW. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-6.19%
TRAW - VTGN
42%
Loosely correlated
N/A
IMNM - VTGN
42%
Loosely correlated
+3.18%
IPSC - VTGN
39%
Loosely correlated
N/A
SYRE - VTGN
38%
Loosely correlated
+1.65%
REPL - VTGN
38%
Loosely correlated
+5.81%
More